Your session is about to expire
← Back to Search
Cancer Episode Payment Model for Cancer Care
N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the health outcomes and costs of care for cancer patients who receive chemotherapy under the HMSA Cancer Episode Payment Model (CEM) with those who receive care under the current fee-for-service model.
Who is the study for?
This trial is for oncologists in Hawaii who are part of the Hawaii Oncology network and treat HMSA members with lung, colorectal, breast, or colon cancer using chemotherapy. It's not open to providers outside this group.
What is being tested?
The trial is testing a new payment model called Cancer Episode Payment Model (CEM) that aims to improve care coordination for cancer patients undergoing chemotherapy and see if it can reduce healthcare costs while improving outcomes.
What are the potential side effects?
Since this trial involves a payment model rather than a medical intervention, there are no direct side effects like those associated with drugs or medical procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Composite quality score
Episode cost
Utilization of acute and specialty care
Secondary study objectives
Quality of care at end of life
Survival
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cancer Episode Payment ModelExperimental Treatment1 Intervention
Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.
Group II: Fee for ServiceActive Control1 Intervention
Oncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,073 Previous Clinical Trials
42,714,249 Total Patients Enrolled
Hawaii Medical Service AssociationOTHER
3 Previous Clinical Trials
230 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Cancer Episode Payment Model
- Group 2: Fee for Service
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger